首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1619034

一次性反應器全球市場規模、佔有率和成長分析：按產品、按細胞類型、按分子類型、按應用、按最終用途、按使用類型、按地區 - 行業預測 (2024-2031)

Single Use Bioreactors Market Size, Share, Growth Analysis, By Product, By Type Of Cell, By Molecule Type, By Application, By End-Use, By Usage Type, By Region - Industry Forecast 2024-2031

出版日期: 2024年12月19日 | 出版商:

SkyQuest | 英文 260 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球一次性反應器市場規模估值為33億美元，從2023年的38.6億美元成長到2031年的136.6億美元，並預計在預測期內成長（2024-預計複合年成長率為2031年為17.1%）。

一次性反應器（SUB）市場預計將顯著成長，因為它在製藥和臨床領域（例如細胞收集、培養和病毒惰性）中發揮著重要作用。這些一次性聚乙烯或聚合物袋由供應商預先消毒，無需對傳統系統進行大量準備和清洗，從而最大限度地減少批次之間的停機時間。隨著對高效療法和生物製藥的需求增加，SUB 的採用預計將加速。其緊湊的台式設計不僅簡化了操作，而且比傳統的不銹鋼反應器具有顯著的成本優勢。因此，人們對 SUB 的營運和經濟優勢的日益認知正在推動其在生物製程開發和最佳化中的廣泛應用，從而支持整體市場成長。

Danaher（USA）
Sartorius AG（Germany）
Thermo Fisher Scientific（USA）
Merck KGaA（Germany）
Pall Corporation（USA）
Eppendorf SE（Germany）
ABEC（USA）
Celltainer（Netherlands）
Distek, Inc.（USA）
OmniBRx Biotechnologies（India）
PBS Biotech, Inc.（USA）
GE Healthcare（USA）
Cellexus Ltd.（UK）
Pierre Guerin（France）
CerCell ApS（Denmark）
Bioengineering AG（Switzerland）
Meissner Filtration Products（USA）
Kuhner Shaker（Switzerland）
Thermo Fisher Scientific（USA）

結論和建議

簡介目錄

Product Code: SQMIG35H2227

Global Single Use Bioreactors Market size was valued at USD 3.3 billion in 2022 and is poised to grow from USD 3.86 billion in 2023 to USD 13.66 billion by 2031, growing at a CAGR of 17.1% during the forecast period (2024-2031).

The market for single-use bioreactors (SUBs) is poised for significant growth, driven by their essential role in the pharmaceutical and clinical sectors for tasks including cell harvesting, culturing, and virus inactivation. These disposable polyethylene and polymer bags, pre-sterilized by suppliers, minimize downtime between batches by eliminating the need for extensive preparation and cleaning of traditional systems. As demand for efficient therapeutics and biopharmaceuticals rises, the adoption of SUBs is expected to accelerate. Their compact, bench-top designs not only streamline operations but also offer considerable cost advantages over traditional stainless-steel bioreactors. Consequently, the increasing realization of SUBs' operational and economic benefits is propelling their widespread use in bioprocess development and optimization, supporting growth in the overall market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Single Use Bioreactors market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Single Use Bioreactors Market Segmental Analysis

Global Single Use Bioreactors Market is segmented by product, type of cell, molecule type, application, end-use, usage type and region. Based on product, the market is segmented into single-use bioreactor systems, single-use media bags, single-use assemblies and other related products. Based on type of cell, the market is segmented into mammalian cells, bacterial cells, yeast cells and other cells. Based on molecule type, the market is segmented into monoclonal antibodies, vaccines, recombinant proteins, stem cells, gene therapy and other molecules. Based on application, the market is segmented into research and development, process development and bioproduction. Based on end-use, the market is segmented into pharmaceutical and biopharmaceutical companies, academic and research institutes, contract research organizations (CROs) and contract manufacturing organizations (CMOs). Based on usage type, the market is segmented into lab-scale production, pilot-scale production and large-scale production. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Single Use Bioreactors Market

The Global Single Use Bioreactors market is experiencing substantial growth driven by the increasing geriatric population and the subsequent demand for biopharmaceuticals. The elderly are more prone to various health issues, creating a heightened need for innovative biopharmaceutical solutions worldwide. In response, companies are investing heavily in research and development (R&D) to enhance product creation and production capabilities. To streamline biopharmaceutical manufacturing processes, single-use technologies have become essential, particularly in clinical trials, research, and small- to medium-scale production. Their numerous advantages over traditional manufacturing methods further promote their adoption, thus indicating a robust expansion in R&D expenditure within the sector.

Restraints in the Global Single Use Bioreactors Market

The Global Single Use Bioreactors market faces significant restraints, primarily stemming from the inadequate availability of reliable, precise, and cost-effective sensors that fulfill the requirements of Single Use Bioreactors (SUBs). These sensors must be compatible with existing SUB platforms to ensure proper system management without compromising material sterility. Historically, the integration of sensors into SUB systems has negatively impacted the quality of the final product. Furthermore, limited scalability represents a critical challenge, as these bioreactors are not well-suited for large-scale production, leading to increased generation of disposable components due to the high volumes of cultures involved.

Market Trends of the Global Single Use Bioreactors Market

The Global Single Use Bioreactors (SUBs) market is experiencing a significant upward trend, driven by the bioprocessing sector's increasing adoption of these technologies. Companies are gravitating towards SUBs due to their inherent advantages, including enhanced flexibility, efficient scalability, and reduced operational time and costs. This shift not only streamlines production processes but also facilitates quicker response to changing market demands. As organizations pursue innovation and optimize manufacturing capabilities, the SUBs market is poised for substantial growth in the coming years, reflecting a broader transformation in bioprocessing methodologies that prioritize efficiency and cost-effectiveness.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Patent Analysis
Case Studies

Global Single Use Bioreactors Market Size by Product & CAGR (2024-2031)

Market Overview
Single-Use Bioreactor Systems
- Stirred Tank
- Wave-Mixed
- Bubble Column
Single-Use Media Bags
Single-Use Assemblies
Other Related Products

Global Single Use Bioreactors Market Size by Type Of Cell & CAGR (2024-2031)

Market Overview
Mammalian Cells
Bacterial Cells
Yeast Cells
Other Cells

Global Single Use Bioreactors Market Size by Molecule Type & CAGR (2024-2031)

Market Overview
Monoclonal Antibodies
Vaccines
Recombinant Proteins
Stem Cells
Gene Therapy
Other Molecules

Global Single Use Bioreactors Market Size by Application & CAGR (2024-2031)

Market Overview
Research and Development
Process Development
Bioproduction

Global Single Use Bioreactors Market Size by End-Use & CAGR (2024-2031)

Market Overview
Pharmaceutical and Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations (CROs)
Contract Manufacturing Organizations (CMOs)

Global Single Use Bioreactors Market Size by Usage Type & CAGR (2024-2031)

Market Overview
Lab-Scale Production
Pilot-Scale Production
Large-Scale Production

Global Single Use Bioreactors Market Size & CAGR (2024-2031)

North America (Product, Type Of Cell, Molecule Type, Application, End-Use, Usage Type)
- USA
- Canada
Europe (Product, Type Of Cell, Molecule Type, Application, End-Use, Usage Type)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Type Of Cell, Molecule Type, Application, End-Use, Usage Type)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Type Of Cell, Molecule Type, Application, End-Use, Usage Type)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Type Of Cell, Molecule Type, Application, End-Use, Usage Type)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Danaher (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pall Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eppendorf SE (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ABEC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Celltainer (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Distek, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OmniBRx Biotechnologies (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PBS Biotech, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cellexus Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pierre Guerin (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CerCell ApS (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioengineering AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meissner Filtration Products (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kuhner Shaker (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments